Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/16778217

Cancer Res. 2006 Jun 15 66 12 6387-94

Download in:

View as

General Info

PMID
16778217